flâneur — a map of the web's best reading

Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review - PMC

ncbi.nlm.nih.gov · 7,217 words · saved by 1 readers

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 1Ph.D. Program in Health Data Science, Faculty of Medicine, University of Porto, 4200-450 Porto, Portugal; moc.liamg@mcsorot 2Center for Minimally Invasive Therapies, Institute of Medical Science Research and Development, Tokyo Medical University, Tokyo 160-8402, Japan; moc.liamg@627imuyza (Y.A.); moc.liamg@1310.uohso (T.S.) 2Center for Minimally Invasive Therapies, Institute of Medical Science Research and Development, Tokyo Medical University, Tokyo 160-8402, Japan; moc.liamg@627imuyza (Y.A.); moc.liamg@1310.uohso (T.S.) 2Center for Minimally Inv

Int J Mol Sci . 2022 Apr 29;23(9):4962. doi: 10.3390/ijms23094962 Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review Serafettin Gunes Serafettin Gunes 1 Ph.D. Program in Health Data Science, Faculty of Medicine, University of Porto, 4200-450 Porto, Portugal; toroscm@gmail.com Find articles by Serafettin Gunes 1 , Yumi Aizawa Yumi Aizawa 2 Center for Minimally Invasive Therapies, Institute of Medical Science Research and Development, Tokyo Medical University, Tokyo 160-8402, Japan; azyumi726@gmail.com (Y.A.); oshou.0131@gmail.com (T.S.) Find articles by Yumi Aizawa 2 ,

Explore this link on the map →

saved by

related reading